Form 4: OmniAb CFO Kurt Gustafson Vests RSUs and Sells for Taxes

OmniAb's Executive VP of Finance and CFO Kurt Gustafson acquired 13,542 shares through RSU vesting and sold 6,913 shares to satisfy mandatory tax obligations.

Summary

• Kurt A. Gustafson, CFO of OmniAb, Inc., executed transactions involving common stock on April 7, 2026.
• A total of 13,542 Restricted Stock Units (RSUs) vested, converting into common stock at a conversion price of $0.
• Following the vesting, 6,913 shares were sold at a weighted average price of $1.49 to cover mandatory tax withholding obligations.
• The reporting person now directly owns 261,483 shares of common stock.
• A prior transfer of 13,997 shares to an ex-spouse occurred on March 11, 2026, pursuant to a domestic relations order.
• The CFO retains 111,042 derivative securities in the form of unvested RSUs.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing typical of executive compensation cycles in publicly traded companies.

Positives

• The CFO maintains a significant direct ownership stake of 261,483 shares, aligning interests with shareholders.
• The vesting of RSUs indicates the executive is meeting service requirements under the company's long-term incentive plan.

Negatives

• The weighted average sale price of $1.49 suggests the stock is trading at a relatively low valuation compared to historical levels.
• Total beneficial ownership was reduced by 13,997 shares in March 2026 due to a domestic relations order.

Risks

• The low share price of $1.49 at the time of the tax-related sale may indicate market volatility or downward pressure on the stock.
• While non-discretionary, the sale of nearly 7,000 shares adds to the daily trading volume and could contribute to minor price pressure.

Future Outlook

The CFO still holds 111,042 unvested RSUs, which are scheduled to vest in future installments, suggesting a continued long-term incentive to remain with the company and drive performance.

Management Comments

• The sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell-to-cover' transaction and do not represent discretionary trades by the reporting person.

Industry Context

StockSavvy.ai notes that 'sell-to-cover' transactions are standard practice for executives in the biotechnology and life sciences sector to manage tax liabilities arising from equity compensation without requiring personal cash outlays.

Comparison to Industry Standards

• OmniAb's use of RSUs with three-year vesting schedules is consistent with standard executive compensation packages in the biotech industry.
• Mandatory 'sell-to-cover' policies are a common governance feature among mid-cap and small-cap firms to simplify tax compliance for insiders.

Related Party Transactions

• Transfer of 13,997 shares to ex-spouse per domestic relations order on March 11, 2026.

Stakeholder Impact

• Minimal impact on shareholders as the sales were non-discretionary and intended solely for tax compliance.

Next Steps

• Remaining 111,042 RSUs will continue to vest according to the established annual schedule.

Key Dates

Recommendation

This is a routine Form 4 filing showing RSU vesting and tax-related sales. It does not provide new fundamental data about the company's operations or financial health that would warrant a change in investment thesis.

Keywords

OmniAb, OABI, Insider Trading, Form 4, CFO, Restricted Stock Units, Executive Compensation, Kurt Gustafson